Fluorescent In Situ Hybridization (FISH).

Adjunct study Chromosome Deoxyribonucleic acid Fluorescent Interphase Ribonucleic acid

Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2022
Historique:
entrez: 3 12 2021
pubmed: 4 12 2021
medline: 29 1 2022
Statut: ppublish

Résumé

In situ hybridization (ISH) is a technique that uses nucleic acid probes to allow for visualization of nucleic acid sequences in cellular/tissue preparations. Both enzymatic and fluorescent ISH studies can be used as adjunct studies, and in some cases are vital to making specific diagnoses. This chapter will focus on fluorescent in situ hybridization.

Identifiants

pubmed: 34859406
doi: 10.1007/978-1-0716-1948-3_12
doi:

Substances chimiques

DNA Probes 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

179-189

Informations de copyright

© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Références

Cassidy A, Jones J (2014) Developments in in situ hybridisation. Methods 70(1):39–45
doi: 10.1016/j.ymeth.2014.04.006
Enns RK, Dewald GW, Barker PE, Rasmussen DJ, Watson M, Wood G, Wyatt PR (2004) NCCLS. Fluorescence in situ hybridization (FISH) methods for medical genetics; approved guideline. NCCLS document MM7-A. clinical and laboratories standards institute (CLSI) (formerly NCCLS), 940 West Valley road, suite 1400, Wayne, Pennsylvania
Steensma D, List AF (2005) Genetic testing in the myelodysplastic syndromes: molecular insights into hematologic diversity. Mayo Clin Proc 80(5):681–698
doi: 10.4065/80.5.681
LSI
Olney H, Le Beau M (2001) The cytogenetics of myelodysplasic syndromes. Best Pract Res Clin Haematol 14(3):479–495
doi: 10.1053/beha.2001.0151
Papenhausen PR, Moscinski LC, Binie CG (1997) Cytogenetic and molecular evaluation in myelodysplastic syndrome and in acute and chronic leukemia. Cancer Control 4(5):389–398
doi: 10.1177/107327489700400501
Witkor AE, Van Dyke DL, Stupca PJ, Ketterling RP, Thorland EC, Shearer BM, Fink SR, Stockero KJ, Majorowicz JR, Dewald GW (2006) Preclinical validation of fluorescence in situ hybridization assays for clinical practice. Genet Med 8(1):16–23
doi: 10.1097/01.gim.0000195645.00446.61
XL DLEU/LAMP DNA probe package insert. Metasystems, Inc. Rev J 150212
Boyum A (1964) Separation of white blood cells. Nature 2–4:793–794
Brown L (1973) Hematology: Principles and Procedures. publ. by Lea and Febinger, Philadelphia

Auteurs

Jeanette M Ramos (JM)

Department of Pathology and Laboratory Services, University of Arkansas for Medical Sciences, Little Rock, AR, USA. JMRamos@uams.edu.

Articles similaires

Animals In Situ Hybridization, Fluorescence RNA, Ribosomal, 5S DNA, Ribosomal Chromosome Mapping

Prognostic implications and diagnostic significance of TFE3 rearrangement in renal cell carcinoma.

Carmina Muñoz Bastidas, Mario Tapia Tapia, Andrés Calva López et al.
1.00
Humans Carcinoma, Renal Cell Basic Helix-Loop-Helix Leucine Zipper Transcription Factors Kidney Neoplasms Middle Aged
Humans Male Middle Aged Adult Female
In Situ Hybridization, Fluorescence Humans Chromosome Aberrations Radiometry Marine Toxins

Classifications MeSH